<p class="MsoNormal">How do GLP-1 receptor agonists and metformin affect glaucoma risk in patients with Type 2 diabetes? Join Dr. Ike Ahmed and Jawad Muayad as they discuss the data on diabetes treatments and glaucoma risk with Dr. Emily Schehlein. From their Ophthalmology article, "<a href= "https://www.aaojournal.org/article/S0161-6420(24)00515-3/fulltext">Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes</a>."</p> <p class="MsoNormal">Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes. Muayad, Jawad et al. Ophthalmology. In press.</p>

Negative Pressure Goggles Reduce IOP

Join Ophthalmology's social media editors as they interview authors and editors of the American Academy of Ophthalmology's journal family: Ophthalmology, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science.